(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AVIPTACARE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

AVIPTACARE

ST13

US500000079319911

Class

5

Filing

79319911

Registration

6776974

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

24

Latest update

09/25/2022

Trademark type

Word

Nice classes

5

Filing date

05/31/2021

Registration date

07/05/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/05/2022

Last transaction

07/05/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

33

Owner location

CH

Examiner

REID, CAILE MAUREEN

Law office

N50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Relief Therapeutics International SA

Representatives

Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationsantivirals; pharmaceutical products for respiratory disorder treatment

Publications

History of USPTO decisions and trademark events.

24 publications found

GPNX

NOTIFICATION PROCESSED BY IB

09/25/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/06/2022

FIMP

FINAL DISPOSITION PROCESSED

09/06/2022

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

08/04/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/05/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

07/05/2022

GPNX

NOTIFICATION PROCESSED BY IB

05/04/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/19/2022

PUBO

PUBLISHED FOR OPPOSITION

04/19/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/13/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

04/13/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/30/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/14/2022

DOCK

ASSIGNED TO EXAMINER

03/09/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/18/2022

DOCK

ASSIGNED TO EXAMINER

02/14/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/20/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/20/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/20/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/20/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/20/2022

MAFR

APPLICATION FILING RECEIPT MAILED

09/18/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/14/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/09/2021

Continuous trademark protection

Get notified about every new filing that threatens AVIPTACARE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.